Clinical Trials · NCT05390307

Obesity Treatment to Improve Diabetes

CompletedN/ASemaglutide (Approved)Liraglutide (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Dasman Diabetes Institute
Enrollment
60
Start date
Apr 2023
Locations
1 site, Kuwait
Primary endpoint
Weight
View Semaglutide compound reference